Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method

被引:55
作者
Teschke, Rolf [1 ,2 ]
机构
[1] Klinikum Hanau, Div Gastroenterol & Hepatol, Dept Internal Med 2, Hanau, Germany
[2] Goethe Univ Frankfurt Main, Acad Teaching Hosp, Med Fac, Frankfurt, Germany
关键词
Drug-induced liver injury; herb-induced liver injury; Roussel Uclaf Causality Assessment Method; alternative causes; DILI registries; clinical DILI centers; ASSESSMENT METHOD RUCAM; HERBAL HEPATOTOXICITY; DIETARY-SUPPLEMENTS; ADVERSE REACTIONS; BLACK COHOSH; BIOMARKERS; DIAGNOSIS; POPULATION; MICRORNAS; PREDICTORS;
D O I
10.1080/17425255.2018.1539077
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Introduction: A list presenting a valid ranking of drugs most commonly implicated is hardly to be found. Areas covered: Published cases of drug-induced liver injury (DILI) with verified causality using RUCAM (Roussel Uclaf Causality Assessment Method) were used for a ranking of drugs most commonly implicated in causing DILI. Expert opinion: RUCAM-based DILI cases were retrieved from 15 reports published by six international databases of DILI registries and three large medical centers, which provided 3312 cases. Overall 48 drugs with the highest number of DILI cases were listed. Among the top 10 ranking drugs implicated in causing DILI were, in decreasing order: amoxicillin-clavulanate, flucloxacilllin, atorvastatin, disulfiram, diclofenac, simvastatin, carbamazepine, ibuprofen, erythromycin, and anabolic steroids as bodybuilding agents. For these 10 drugs, respective DILI case numbers were highest for Amoxicillin-clavulanate (n=333) and lowest for anabolic steroids (n=26). The author classifies the databases of national DILI registries and large medical centers as best sources of drugs implicated in DILI. Presently discouraged is the use of the LiverTox website because many cases were derived from published cases of poor quality and could previously not be classified as DILI, calling for the inclusion of DILI cases with established causality by the updated RUCAM.
引用
收藏
页码:1169 / 1187
页数:19
相关论文
共 84 条
[1]
Case Definition and Phenotype Standardization in Drug-Induced Liver Injury [J].
Aithal, G. P. ;
Watkins, P. B. ;
Andrade, R. J. ;
Larrey, D. ;
Molokhia, M. ;
Takikawa, H. ;
Hunt, C. M. ;
Wilke, R. A. ;
Avigan, M. ;
Kaplowitz, N. ;
Bjornsson, E. ;
Daly, A. K. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) :806-815
[2]
Aithal GP, 1999, BMJ-BRIT MED J, V319, P154
[3]
Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice [J].
Aithal, Guruprasad P. .
LIVER INTERNATIONAL, 2015, 35 (07) :1801-1808
[4]
The natural history of histologically proved drug induced liver disease [J].
Aithal, PG ;
Day, CP .
GUT, 1999, 44 (05) :731-735
[5]
Outcome of acute idiosyncratic drug-induced liver injury:: Long-term follow-up in a hepatotoxicity registry [J].
Andrade, Raul J. ;
Lucena, M. Isabel ;
Kaplowitz, Neil ;
Garcia-Munoz, Beatriz ;
Borraz, Yolanda ;
Pachkoria, Ketevan ;
Garcia-Cortes, Miren ;
Fernandez, M. Carmen ;
Pelaez, Gloria ;
Rodrigo, Luis ;
Duran, Jose A. ;
Costa, Joan ;
Planas, Ramon ;
Barriocanal, Anabel ;
Guarner, Carlos ;
Romero-Gomez, Manuel ;
Munoz-Yague, Teresa ;
Salmeron, Javier ;
Hidalgo, Ramon .
HEPATOLOGY, 2006, 44 (06) :1581-1588
[6]
Drug-induced liver injury:: An analysis of 461 incidences submitted to the Spanish Registry over a 10-year period [J].
Andrade, RJ ;
Lucena, MI ;
Fernández, MC ;
Pelaez, G ;
Pachkoria, K ;
García-Ruiz, E ;
García-Munoz, B ;
González-Grande, R ;
Pizarro, A ;
Durán, JA ;
Jiménez, M ;
Rodrigo, L ;
Romero-Gomez, M ;
Navarro, JM ;
Planas, R ;
Costa, J ;
Borras, A ;
Soler, A ;
Salmerón, J ;
Martin-Vivaldi, R .
GASTROENTEROLOGY, 2005, 129 (02) :512-521
[7]
CAUSALITY ASSESSMENT OF ADVERSE REACTIONS TO DRUGS .2. AN ORIGINAL MODEL FOR VALIDATION OF DRUG CAUSALITY ASSESSMENT METHODS - CASE-REPORTS WITH POSITIVE RECHALLENGE [J].
BENICHOU, C ;
DANAN, G ;
FLAHAULT, A .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (11) :1331-1336
[8]
Outcome and prognostic markers in severe drug-induced liver disease [J].
Björnsson, E ;
Olsson, R .
HEPATOLOGY, 2005, 42 (02) :481-489
[9]
Björnsson E, 2012, J HEPATOL, V56, P374, DOI [10.1016/j.jhep.2011.07.023, 10.1016/j.jhep.2011.08.016]
[10]
Hepatotoxicity by Drugs: The Most Common Implicated Agents [J].
Bjornsson, Einar S. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (02)